Status:
ACTIVE_NOT_RECRUITING
Foam and Liquid Sclerotherapy With or Without Herbal Gel for Small Vein Treatment
Lead Sponsor:
Kafrelsheikh University
Conditions:
Telangectasia
Reticular Veins
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Telangiectasias (spider veins) and reticular veins represent early and common manifestations of chronic venous insufficiency . Telangiectasias are dilated intradermal venules or capillaries less than ...
Detailed Description
Telangiectasias, also known as spider veins, are dilated intradermal venules less than 1 mm in diameter. They often appear close to the surface of the skin in a tree-like pattern and may be red, blue,...
Eligibility Criteria
Inclusion
- telangiectasis on thigh or leg side
- Competent saphenofemoral and saphenopoliteal junction
- Patient post surgical stripping or post thermal ablation
- clinical classification of chronic venous disease C1(mild venous disease), -
- minimum age of 18 year-old and maximum age 65 year-old -
Exclusion
- varicose disease in any quantity or location with clinical classification of chronic venous
- disease different of C1(mild venous disease)
- arterial insufficiency
- patient allergic to the sclerosant material or herbal gel
- dermatitis on application site
- patient with serious comorbidities like heart failure, respiratory failure, - uncontrolled hypertension with medication, and uncontrolled hypothyroidism - pregnancy - previous deep vein thrombosis (DVT) - family history of DVT - thrombophilia
Key Trial Info
Start Date :
September 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
508 Patients enrolled
Trial Details
Trial ID
NCT07162844
Start Date
September 5 2024
End Date
September 1 2025
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine kfs university
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt, 33511